Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiac arrest; Myocardial infarction; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority-WEB NL-LRB-00534918, received from Regulatory Authority. A 74-year-old male patient received first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 11Apr2021 (Batch/Lot Number: ET9096) as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. Patient didn''t have COVID-19 infection previous. The patient experienced cardiac arrest on 03May2021, Myocardial infarction (Heart attack) followed by cardiac arrest. Cardiac ultrasound in emergency room hospital. Both events treated with Reanimatie. The outcome of cardiac arrest and heart attack was fatal. Patient died on 03May2021. It was unknown if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Myocardial infarction; Cardiac arrest
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166